CHI3L1 and Alzheimer disease: In another validation cohort (N = 237; Age: ≥ 60 years) at Washington University Alzheimer’s Disease Research Center (WU-ADRC), the plasma CHI3L1 levels were significantly higher in AD than in the HC and were affected by the age, and not by the sex [48].